» Articles » PMID: 9096140

Heterogeneous Topographic and Cellular Distribution of Huntingtin Expression in the Normal Human Neostriatum

Overview
Journal J Neurosci
Specialty Neurology
Date 1997 May 1
PMID 9096140
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

A striking heterogeneous distribution of topographic and cellular huntingtin immunoreactivity was observed within the human neostriatum using three distinct huntingtin antibodies. Patchy areas of low huntingtin immunoreactivity were present in both the caudate nucleus and putamen, surrounded by an intervening area of greater immunoreactivity. Comparison of huntingtin immunoreactivity with contiguous serial sections stained for enkephalin and calbindin D28k immunoreactivities showed that the topographic heterogeneity of huntingtin immunostaining corresponded to the patch (striosome) and matrix compartments within the striatum. Huntingtin immunoreactivity was confined primarily to neurons and neuropil within the matrix compartment, whereas little or no neuronal or neuropil huntingtin immunostaining was observed within the patch compartment. There was marked variability in the intensity of huntingtin immunolabel among medium-sized striatal neurons, whereas a majority of large striatal neurons were only faintly positive or without any immunoreactivity. Combined techniques for NADPH-diaphorase enzyme histochemistry and huntingtin immunocytochemistry, as well as double immunofluorescence for either nitric oxide synthase or calbindin D28k in comparison with huntingtin expression, revealed a striking correspondence between calbindin D28k and huntingtin immunoreactivities, with little or no colocalization between NADPH-diaphorase or nitric oxide synthase neurons and huntingtin expression. These observations suggest that the selective vulnerability of spiny striatal neurons and the matrix compartment observed in Huntington's disease is associated with higher levels of huntingtin expression, whereas the relative resistance of large and medium-sized aspiny neurons and the patch compartments to degeneration is associated with low levels of huntingtin expression.

Citing Articles

A guide to selecting high-performing antibodies for Huntingtin (UniProt ID: P42858) for use in western blot, immunoprecipitation, and immunofluorescence.

Fanti R, Ayoubi R, Alende C, Fotouhi M, Gonzalez Bolivar S, Chandrasekaran R F1000Res. 2024; 13:922.

PMID: 39257448 PMC: 11384196. DOI: 10.12688/f1000research.153670.1.


TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington's disease.

Qin Y, Chen L, Zhu W, Song J, Lin J, Li Y Sci Adv. 2024; 10(20):eadl2036.

PMID: 38758800 PMC: 11100560. DOI: 10.1126/sciadv.adl2036.


The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade.

Hickman R, Faust P, Marder K, Yamamoto A, Vonsattel J Acta Neuropathol Commun. 2022; 10(1):55.

PMID: 35440014 PMC: 9020040. DOI: 10.1186/s40478-022-01364-1.


RTP801/REDD1 Is Involved in Neuroinflammation and Modulates Cognitive Dysfunction in Huntington's Disease.

Perez-Sisques L, Solana-Balaguer J, Campoy-Campos G, Martin-Flores N, Sancho-Balsells A, Vives-Isern M Biomolecules. 2022; 12(1).

PMID: 35053183 PMC: 8773874. DOI: 10.3390/biom12010034.


Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington's Disease.

Kim A, Garcia-Garcia E, Straccia M, Comella-Bolla A, Miguez A, Masana M Front Cell Neurosci. 2020; 14:163.

PMID: 32625064 PMC: 7314984. DOI: 10.3389/fncel.2020.00163.


References
1.
Hope B, Michael G, Knigge K, Vincent S . Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A. 1991; 88(7):2811-4. PMC: 51329. DOI: 10.1073/pnas.88.7.2811. View

2.
Faull R, Waldvogel H, Nicholson L, Synek B . The distribution of GABAA-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat. Prog Brain Res. 1993; 99:105-23. DOI: 10.1016/s0079-6123(08)61341-2. View

3.
Reiner A, Albin R, Anderson K, DAMATO C, Penney J, Young A . Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A. 1988; 85(15):5733-7. PMC: 281835. DOI: 10.1073/pnas.85.15.5733. View

4.
Bhide P, Day M, Sapp E, Schwarz C, Sheth A, Kim J . Expression of normal and mutant huntingtin in the developing brain. J Neurosci. 1996; 16(17):5523-35. PMC: 6578889. View

5.
Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y . Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet. 1995; 10(1):104-10. DOI: 10.1038/ng0595-104. View